| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |